A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity
| Huvudupphovsmän: | , , , , , , , , , |
|---|---|
| Materialtyp: | Conference item |
| Publicerad: |
BMJ Publishing Group
2019
|
| Sammanfattning: |
|---|